Delivering the next generation drug discovery pipeline

On 1st May 2020, the Psychiatry Consortium and Psychiatric Genomics Consortium co-hosted a workshop to bring together key opinion leaders and experts from the worlds of pharma, biotech, academia and the charity sector. The workshop aimed to discuss the challenges that arise in the early stages of the psychiatric drug discovery pipeline and how we can collaborate to take advantage of opportunities in these areas in the future.